Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04038541 · ClinicalTrials.gov registry record · NA
Prebiotic vs Probiotic in Multiple Sclerosis
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
NCT04038541 is a NA study that has completed, run by Columbia University. The registered enrollment target is 37 participants.
The verdict
NCT04038541, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
Study Summary
This is a randomized crossover-designed study to explore the immunologic effects of Prebiotics, as opposed to direct supplementation with beneficial bacteria (Probiotics) in the immune system of patients with MS and Clinically Isolated Syndrome (CIS). Eligible patients will take 6 weeks of two different supplements - Prebiotics and Probiotics. Participants will be randomly assigned to take either of two agents for 6 weeks as their first supplement. Then, participants enter a 6-week washout period. After the washout period, participants will take the second supplement for 6 weeks. After taking the second supplement, participants will have a 6-week washout period.
Interventions
- DIETARY_SUPPLEMENT Prebiotics (Prebiotin Prebiotic Fiber Stick Pac)
- DIETARY_SUPPLEMENT Probiotics (Visbiome®)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2020-03-11 |
| Est. Completion | 2023-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04038541
The ClinicalTrials.gov registry entry for NCT04038541 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Prebiotics (Prebiotin Prebiotic Fiber Stick Pac) is the first listed.
NCT04038541 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04038541 about?
NCT04038541 is a clinical study titled "Prebiotic vs Probiotic in Multiple Sclerosis". This is a randomized crossover-designed study to explore the immunologic effects of Prebiotics, as opposed to direct supplementation with beneficial bacteria (Probiotics) in the immune system of patients with MS and Clinically Isolated Syndrome (CIS). Eligible patients will take 6 weeks of two diffe...
What is the current status of trial NCT04038541?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2020-03-11. Estimated completion is 2023-12-30.
What interventions are being tested in trial NCT04038541?
The interventions under investigation include: Prebiotics (Prebiotin Prebiotic Fiber Stick Pac) (DIETARY_SUPPLEMENT), Probiotics (Visbiome®) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04038541?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.